• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-125b 通过靶向 E2F3 抑制膀胱癌的发展。

MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.

机构信息

Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Int J Cancer. 2011 Apr 15;128(8):1758-69. doi: 10.1002/ijc.25509.

DOI:10.1002/ijc.25509
PMID:20549700
Abstract

Increasing evidence has suggested that dysregulation of certain microRNAs (miRNAs) may contribute to tumorigenesis. microRNA-125b (miR-125b) was implicated to have close relationship with cell proliferation and differentiation, and downregulation of miR-125b was observed in various types of cancers. However, the biological function of miR-125b in bladder tumorigenesis is still unknown. In our study, we showed that the expression of miR-125b was significantly decreased in bladder cancer tissues and four bladder cancer cell lines. Moreover, miR-125b could suppress bladder cancer cells to form colonies in vitro and to develop tumors in nude mice. E2F3, which was critical for G1/S transition and was overexpressed in most of poor-differentiated bladder cancers, was identified as a target of miR-125b by luciferase assay. The E2F3 mRNA and protein expression levels were detected in bladder cancer tissues and cell lines, and interestingly, inverse correlations between miR-125b and E2F3 protein level were found in bladder cancer tissues and four E2F3 nonamplified cell lines. Introduction of miR-125b could reduce the expression of E2F3 protein but not the E2F3 mRNA. In addition, we observed that transfection of miR-125b could inhibit the expression of Cyclin A2, one of the E2Fs-responsive genes involved in G1/S transition. These results suggest that miR-125b may regulate G1/S transition through the E2F3-Cyclin A2 signaling pathway. Taken together, miR-125b may act as a tumor suppressor in bladder urothelium, and downregulation of miR-125b may contribute to the tumorigenesis of bladder cancer.

摘要

越来越多的证据表明,某些 microRNAs(miRNAs)的失调可能与肿瘤发生有关。microRNA-125b(miR-125b)与细胞增殖和分化密切相关,在各种类型的癌症中观察到 miR-125b 的下调。然而,miR-125b 在膀胱癌发生中的生物学功能尚不清楚。在我们的研究中,我们表明 miR-125b 的表达在膀胱癌组织和四种膀胱癌细胞系中显著降低。此外,miR-125b 可以抑制膀胱癌细胞在体外形成集落并在裸鼠中形成肿瘤。E2F3 对于 G1/S 转换至关重要,并且在大多数低分化膀胱癌中过度表达,通过荧光素酶测定被鉴定为 miR-125b 的靶标。检测了膀胱癌组织和细胞系中的 E2F3 mRNA 和蛋白表达水平,有趣的是,在膀胱癌组织和四种 E2F3 非扩增细胞系中发现 miR-125b 与 E2F3 蛋白水平呈负相关。引入 miR-125b 可以降低 E2F3 蛋白的表达,但不影响 E2F3 mRNA 的表达。此外,我们观察到 miR-125b 的转染可以抑制 E2Fs 反应基因之一 Cyclin A2 的表达,该基因参与 G1/S 转换。这些结果表明,miR-125b 可能通过 E2F3-Cyclin A2 信号通路调节 G1/S 转换。总之,miR-125b 可能在膀胱尿路上皮中作为肿瘤抑制因子发挥作用,miR-125b 的下调可能有助于膀胱癌的发生。

相似文献

1
MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.MicroRNA-125b 通过靶向 E2F3 抑制膀胱癌的发展。
Int J Cancer. 2011 Apr 15;128(8):1758-69. doi: 10.1002/ijc.25509.
2
MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.微小RNA-497通过靶向E2F3抑制人膀胱移行细胞癌细胞的增殖、迁移和侵袭。
Oncol Rep. 2016 Sep;36(3):1293-300. doi: 10.3892/or.2016.4923. Epub 2016 Jul 8.
3
[miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].[微小RNA-503-5p通过干扰Rb/E2F信号通路抑制T24和EJ膀胱癌细胞的增殖]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Oct;33(10):1360-1364.
4
MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.MicroRNA-503 通过下调肝细胞癌中的细胞周期蛋白 D3 和 E2F3 来抑制 G1/S 期转换。
J Transl Med. 2013 Aug 22;11:195. doi: 10.1186/1479-5876-11-195.
5
miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.微小RNA-200c通过下调BMI-1和E2F3抑制膀胱癌细胞的侵袭、迁移和增殖。
J Transl Med. 2014 Nov 4;12:305. doi: 10.1186/s12967-014-0305-z.
6
MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.微小RNA-155通过抑制肿瘤抑制因子DMTF1促进膀胱癌生长。
Oncotarget. 2015 Jun 30;6(18):16043-58. doi: 10.18632/oncotarget.3755.
7
miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.miR-451 通过直接靶向 c-Myc 抑制膀胱癌细胞迁移和侵袭。
Oncol Rep. 2016 Oct;36(4):2049-58. doi: 10.3892/or.2016.5040. Epub 2016 Aug 25.
8
miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.miR-34c 在前列腺癌中下调,并发挥肿瘤抑制功能。
Int J Cancer. 2010 Dec 15;127(12):2768-76. doi: 10.1002/ijc.25269.
9
MiR-194-5p inhibits cell migration and invasion in bladder cancer by targeting E2F3.微小RNA-194-5p通过靶向E2F3抑制膀胱癌细胞的迁移和侵袭。
J BUON. 2018 Sep-Oct;23(5):1492-1499.
10
MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.微小RNA-218通过靶向BMI-1抑制膀胱癌细胞的增殖、迁移和侵袭。
Tumour Biol. 2015 Sep;36(10):8015-23. doi: 10.1007/s13277-015-3532-x. Epub 2015 May 14.

引用本文的文献

1
Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications.膀胱癌中的核受体:对miRNA介导的调控及潜在治疗意义的见解
Int J Mol Sci. 2025 Jul 29;26(15):7340. doi: 10.3390/ijms26157340.
2
Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment.天然化合物作为微小RNA的调节剂:膀胱癌治疗的新前沿。
Med Oncol. 2025 Jan 30;42(3):56. doi: 10.1007/s12032-025-02613-8.
3
miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine.
miR-125在乳腺癌病因发病机制中的作用:作为鉴别诊断、再生医学及个性化医学挑战中的生物标志物的新角色
Noncoding RNA. 2024 Feb 21;10(2):16. doi: 10.3390/ncrna10020016.
4
Dynamic altruistic cooperation within breast tumors.乳腺肿瘤内的动态利他合作。
Mol Cancer. 2023 Dec 14;22(1):206. doi: 10.1186/s12943-023-01896-7.
5
The Tumorigenicity of Breast Cancer Cells Is Reduced upon Treatment with Small Extracellular Vesicles Isolated from Heparin Treated Cell Cultures.经肝素处理的细胞培养物中分离出的小细胞外囊泡处理后,乳腺癌细胞的致瘤性降低。
Int J Mol Sci. 2023 Oct 29;24(21):15736. doi: 10.3390/ijms242115736.
6
Epigenetic and Immunological Features of Bladder Cancer.膀胱癌的表观遗传和免疫学特征。
Int J Mol Sci. 2023 Jun 7;24(12):9854. doi: 10.3390/ijms24129854.
7
Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition.ncRNAs 通过调控细胞周期影响 CDK4/6 抑制的效率。
Int J Mol Sci. 2023 May 18;24(10):8939. doi: 10.3390/ijms24108939.
8
miR-125b-5p, miR-155-3p, and miR-214-5p and Target Gene in Oral Squamous Cell Carcinoma.miR-125b-5p、miR-155-3p 和 miR-214-5p 及其在口腔鳞状细胞癌中的靶基因。
Int J Mol Sci. 2023 Mar 28;24(7):6320. doi: 10.3390/ijms24076320.
9
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.细胞周期相关的微小RNA作为肺癌治疗的靶点和疗法
Heliyon. 2022 Oct 13;8(10):e11081. doi: 10.1016/j.heliyon.2022.e11081. eCollection 2022 Oct.
10
Proteomics, Phosphoproteomics and Mirna Analysis of Circulating Extracellular Vesicles through Automated and High-Throughput Isolation.通过自动化和高通量分离对循环细胞外囊泡进行蛋白质组学、磷酸化蛋白质组学和 miRNA 分析。
Cells. 2022 Jun 29;11(13):2070. doi: 10.3390/cells11132070.